Levy R - Search Results

1

Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.

Kohrt HE, Houot R, Weiskopf K, Goldstein MJ, Scheeren F, Czerwinski D, Colevas AD, Weng WK, Clarke MF, Carlson RW, Stockdale FE, Mollick JA, Chen L, Levy R. Kohrt HE, et al. Among authors: levy r. J Clin Invest. 2019 Jun 3;129(6):2595. doi: 10.1172/JCI129688. Epub 2019 Jun 3. J Clin Invest. 2019. PMID: 31157620 Free PMC article. No abstract available.

2

Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma.

Weng WK, Levy R. Weng WK, et al. Among authors: levy r. Blood. 2001 Sep 1;98(5):1352-7. doi: 10.1182/blood.v98.5.1352. Blood. 2001. PMID: 11520782 Free article.

3

Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma.

Weng WK, Levy R. Weng WK, et al. Among authors: levy r. J Clin Oncol. 2003 Nov 1;21(21):3940-7. doi: 10.1200/JCO.2003.05.013. Epub 2003 Sep 15. J Clin Oncol. 2003. PMID: 12975461

4

Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype.

Weng WK, Czerwinski D, Timmerman J, Hsu FJ, Levy R. Weng WK, et al. Among authors: levy r. J Clin Oncol. 2004 Dec 1;22(23):4717-24. doi: 10.1200/JCO.2004.06.003. Epub 2004 Oct 13. J Clin Oncol. 2004. PMID: 15483014

5

Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapy.

Weng WK, Czerwinski D, Levy R. Weng WK, et al. Among authors: levy r. Blood. 2007 Feb 1;109(3):951-3. doi: 10.1182/blood-2006-03-013136. Epub 2006 Oct 10. Blood. 2007. PMID: 17032925 Free PMC article.

6

Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors.

Brody JD, Goldstein MJ, Czerwinski DK, Levy R. Brody JD, et al. Among authors: levy r. Blood. 2009 Jan 1;113(1):85-94. doi: 10.1182/blood-2008-05-155457. Epub 2008 Sep 23. Blood. 2009. PMID: 18812472 Free PMC article.

7

T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy.

Houot R, Levy R. Houot R, et al. Among authors: levy r. Blood. 2009 Apr 9;113(15):3546-52. doi: 10.1182/blood-2008-07-170274. Epub 2008 Oct 21. Blood. 2009. PMID: 18941113 Free PMC article.

8

Vaccines for lymphomas: idiotype vaccines and beyond.

Houot R, Levy R. Houot R, et al. Among authors: levy r. Blood Rev. 2009 May;23(3):137-42. doi: 10.1016/j.blre.2008.09.001. Epub 2008 Oct 31. Blood Rev. 2009. PMID: 18951668 Review.

9

Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma.

Timmerman JM, Vose JM, Czerwinski DK, Weng WK, Ingolia D, Mayo M, Denney DW, Levy R. Timmerman JM, et al. Among authors: levy r. Leuk Lymphoma. 2009 Jan;50(1):37-46. doi: 10.1080/10428190802563355. Leuk Lymphoma. 2009. PMID: 19125383 Free PMC article. Clinical Trial.

10

Idiotype vaccination for lymphoma: moving towards optimisation.

Houot R, Levy R. Houot R, et al. Among authors: levy r. Leuk Lymphoma. 2009 Jan;50(1):1-2. doi: 10.1080/10428190802517807. Leuk Lymphoma. 2009. PMID: 19172492 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,959 results

Search Page

Filters